ArticleOphthalmology science2026
Large Language Models Approximate Inter-Expert Agreement in Glaucoma Suspect and Glaucoma Classification from Multimodal Data.
Article in Ophthalmology science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Objective: To assess whether publicly available large language models (LLMs), when provided cross-sectional multimodal clinical inputs, can classify glaucoma versus glaucoma suspect with diagnostic agreement comparable to fellowship-trained glaucoma specialists when benchmarked against consensus-derived reference standards. Design: Observational cross-sectional study. Subjects and Controls: A total of 230 eyes from 131 consecutive participants evaluated at a tertiary academic glaucoma referral center in the United States between 2016 and 2022 were included. The eye was the unit of analysis. No separate external control group was used; comparisons were made against peer-derived consensus reference standards. Methods: Seven LLM configurations (GPT-5 Pro, GPT-5.2, Gemini 3 Pro under two prompts, and Grok 2.2 under 1 prompt) were tested without task-specific training using multimodal inputs including age, sex, race, visual acuity, intraocular pressure, fundus photographs, OCT retinal nerve fiber layer reports, and visual field reports. Four peer-derived reference standards were constructed using a leave-one-out majority consensus approach among four fellowship-trained glaucoma specialists who independently graded the complete data. Main Outcomes and Measures: Diagnostic agreement for classification as glaucoma suspect or glaucoma was assessed using accuracy, sensitivity, specificity, F1 score, and Cohen's κ. Results: Among 230 eyes of 131 patients (72 women [55%]; 49 Asian, 10 Black, 56 Caucasian, 50 Hispanic, and 65 other), mean (standard deviation) age was 67.4 (13.8) years, and 43.5% to 56.5% of eyes were classified as glaucoma. Glaucoma specialist accuracy ranged from 71.3% to 83.9% (κ = 0.46-0.68). GPT-5 Pro (long prompt) achieved accuracies of 80.4% to 85.7% (κ = 0.61-0.71), and Gemini 3 Pro (long prompt) achieved accuracies of 80.9% to 84.3% (κ = 0.62-0.68), each achieving the highest accuracy in two reference sets. GPT-5.2 demonstrated intermediate performance; Grok 2.2 performed near chance. Agreement was highest for moderate-to-severe glaucoma and lower for glaucoma suspect and mild glaucoma. Conclusions: Publicly available multimodal LLMs achieved diagnostic agreement comparable to inter-expert agreement among glaucoma specialists without task-specific training. These findings support further investigation of LLMs as scalable, standardized clinical decision-support tools in glaucoma care. Financial Disclosures: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.